Indication:? \nBarif^TM?is indicated for the chronic management of hyperuricemia in patients with gout. Barif^TM?is not recommended for the treatment of asymptomatic hyperuricemia.

\n

Dosage & Administration: \nBarif^TM?is recommended at 40 mg or 80 mg once daily. The recommended starting dose of Barif? is 40 mg once daily. For patients who do not achieve a serum uric acid less than 6 mg /dL after 2 weeks with 40 mg, Barif^TM?80 mg is recommended.

\nBarif^TM?can be administered without regard to food or antacid use. No dose adjustment is necessary when administering Febuxostat to patients with mild to moderate renal or hepatic impairment.